Yoshitaka Nishikawa1, Masashi Kanai1,2, Maiko Narahara3,4, Akiko Tamon5, J B Brown5,6, Kei Taneishi5,7, Masahiko Nakatsui5, Kazuya Okamoto8, Yu Uneno1, Daisuke Yamaguchi1, Teruko Tomono9, Yukiko Mori1,2, Shigemi Matsumoto1, Yasushi Okuno5,7, Manabu Muto10. 1. Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan. 2. Department of Clinical Oncology, Pharmacogenomics, and Palliative Medicine, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 3. Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, 53 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 4. Department of Human Genetics, McGill University, 740 Dr. Penfield Avenue, Montréal, H3A 0G1, Canada. 5. Department of Clinical System Onco-Informatics, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 6. Center for Medical Education, Graduate School of Medicine, Kyoto University, Konoemachi Med Bldg E, Sakyo-ku, Kyoto, 606-8501, Japan. 7. RIKEN Advanced Institute for Computational Science, 7-1-26 Minatojima-minami-machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan. 8. Division of Medical Information Technology and Administration Planning, Kyoto University Hospital, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 9. Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. 10. Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Kyoto, 606-8507, Japan. mmuto@kuhp.kyoto-u.ac.jp.
Abstract
BACKGROUND: Lung cancer is the leading cause of cancer death and is closely linked to tobacco smoking. Genetic polymorphisms in genes that encode enzymes involved in metabolizing tobacco carcinogens could affect an individual's risk for lung cancer. While polymorphism of UDP-glucuronosyltransferase1A1 (UGT1A1) is involved in detoxification of benzo(a)pyrene-7,8-dihydrodiol(-), a major tobacco carcinogen, the association between UGT1A1 genotype and lung cancer has not been examined. METHODS: We retrieved the clinical data of 5,285 patients who underwent systemic chemotherapy at Kyoto University Hospital. A total of 765 patients (194 lung cancer patients and 671 patients with other malignancies) with UGT1A1 genotyping data were included in this analysis. We used logistic regression with recessive, dominant, and additive models to identify differences in genotype frequencies between lung cancer and other malignancies. RESULTS: In the recessive model, UGT1A1*28*28 genotype was significantly associated with lung cancer compared to other malignancies (odds ratio 5.3, P = 0.0083). Among lung cancer patients with a smoking history, squamous cell carcinoma was significantly predominant in patients with UGT1A1*28*28 compared to those with other UGT1A1 genotypes (P = 0.024). CONCLUSION: This is the first study to demonstrate a significant association between the homozygous UGT1A1*28 genotype and lung cancer.
BACKGROUND:Lung cancer is the leading cause of cancer death and is closely linked to tobacco smoking. Genetic polymorphisms in genes that encode enzymes involved in metabolizing tobacco carcinogens could affect an individual's risk for lung cancer. While polymorphism of UDP-glucuronosyltransferase1A1 (UGT1A1) is involved in detoxification of benzo(a)pyrene-7,8-dihydrodiol(-), a major tobacco carcinogen, the association between UGT1A1 genotype and lung cancer has not been examined. METHODS: We retrieved the clinical data of 5,285 patients who underwent systemic chemotherapy at Kyoto University Hospital. A total of 765 patients (194 lung cancerpatients and 671 patients with other malignancies) with UGT1A1 genotyping data were included in this analysis. We used logistic regression with recessive, dominant, and additive models to identify differences in genotype frequencies between lung cancer and other malignancies. RESULTS: In the recessive model, UGT1A1*28*28 genotype was significantly associated with lung cancer compared to other malignancies (odds ratio 5.3, P = 0.0083). Among lung cancerpatients with a smoking history, squamous cell carcinoma was significantly predominant in patients with UGT1A1*28*28 compared to those with other UGT1A1 genotypes (P = 0.024). CONCLUSION: This is the first study to demonstrate a significant association between the homozygous UGT1A1*28 genotype and lung cancer.
Authors: Sara Gandini; Edoardo Botteri; Simona Iodice; Mathieu Boniol; Albert B Lowenfels; Patrick Maisonneuve; Peter Boyle Journal: Int J Cancer Date: 2008-01-01 Impact factor: 7.396
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Nazlisadat Seyed Khoei; Robert Carreras-Torres; Neil Murphy; Marc J Gunter; Paul Brennan; Karl Smith-Byrne; Daniela Mariosa; James Mckay; Tracy A O'Mara; Ruth Jarrett; Henrik Hjalgrim; Karin E Smedby; Wendy Cozen; Kenan Onel; Arjan Diepstra; Karl-Heinz Wagner; Heinz Freisling Journal: Cells Date: 2021-02-15 Impact factor: 6.600
Authors: Esdras E B Pereira; Luciana P C Leitão; Roberta B Andrade; Antônio A C Modesto; Bruno M Fernandes; Rommel M R Burbano; Paulo P Assumpção; Marianne R Fernandes; João F Guerreiro; Sidney E B Dos Santos; Ney P C Dos Santos Journal: Genes (Basel) Date: 2022-03-11 Impact factor: 4.096